Sydney researcher Adam Cawley has won the 2007 Manfred Donike prize for scientific excellence.

Can Tim Flannery make it three in a row for science in the Australian of the Year awards tomorrow?

Evolution is being harnessed for modern drug development by West Australian biotech Phylogica.

So, you're a small biotech looking to get into bed with Big Pharma. Kate McDonald spoke to Merck's head of research Ismail Kola about life on the dark side.

Graeme O'Neill speaks with RNAi pioneer Peter Waterhouse and meets Drosha, Dicer, Argonaute and other characters.

Professor John Mattick is challenging the orthodoxy that selfish DNA is the cornerstone of the genome. Regulatory RNA is where it's all happening, as Graeme O'Neill reports.

The international Human Variome Project is up and running following a highly successful first meeting in Melbourne in June.

AgResearch, the largest of New Zealand's crown research institutes, has formed a new company with San Diego venture capital firm Finistere Partners, to commercialise its plant genome technology in the US.

Western Australia's agriculture minister, Kim Chance, is taking what many are now seeing as an overly cautious stance on biotechnology. Graeme O'Neill reports.

Paul Trainor AO, 78, 'father of Australia's medical device industry' died on January 13, 2006.

AusBiotech and its South Korean equivalent, the Bioindustry Association of Korea (BAK), have signed an agreement that they hope will lead to a stronger relationship between the two countries' biotech industries.